PMID- 29356954 OWN - NLM STAT- MEDLINE DCOM- 20190404 LR - 20221207 IS - 1432-0711 (Electronic) IS - 0932-0067 (Linking) VI - 297 IP - 3 DP - 2018 Mar TI - Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome. PG - 757-766 LID - 10.1007/s00404-018-4662-3 [doi] AB - PURPOSE: This study aims to investigate the association of human leukocyte antigen (HLA) alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer (SCC). METHODS: A total of 131 Uyghur patients with advanced SCC (IIb-IVa) and 91 healthy subjects from Xinjiang province were genotyped for HLA-I and II genes using Polymerase Chain Reaction Sequence Based Typing. The different frequencies of HLA alleles and haplotypes between patients and controls were compared and the correlations were analyzed between HLA distribution and HPV status and prognosis. RESULTS: (1) The frequencies of B*51:01, DRB1*07:01, DQB1*02:01, A*01:01-C*06:02, A*01:01-DRB1*07:01, C*06:02-DQB1*02:01, DRB1*07:01-DQB1*02:01 and C*06:02-DRB1*07:01-DQB1*02:01 in cancer group were higher than control group whereas the frequencies of B*44:02, B*58:01, C*05:01, DRB1*04:01, DRB1*12:01, DRB1*13:01, DQB1*02:02, DQB1*05:02, DRB1*03:01-DQB1*02:02 and DRB1*04:01-DQB1*03:02 in cancer group were lower than control group (P < 0.05). (2) The frequencies of A*01:01-C*06:02, A*01:01-DRB1*07:01, C*06:02-DQB1*02:01, DRB1*07:01-DQB1*02:01 and C*06:02-DRB1*07:01-DQB1*02:01 in HPV positive group were lower than HPV negative group, differences of which were statistically significant (P < 0.05). (3) B*44:02 and B*58:01 were associated with reduced disease-specific survival (DSS) (P = 0.010 and 0.007). (4) Multivariate Cox proportional hazard models revealed that age, International Federation of Gynaecology and Obstetrics (FIGO) stage, tumor differentiation and allele B*58:01 as independent predictors for DSS while FIGO stage and tumor differentiation as independent factors for DFS. CONCLUSIONS: In the development and progression of advanced SCC among Uyghur population, the HLA alleles and its haplotypes play an important role. B*58:01 allele may act as an independent predictor for DSS. FAU - Alifu, Mayinuer AU - Alifu M AD - Department of Radiation Oncology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, Xinjiang, China. FAU - Fan, Peiwen AU - Fan P AD - Key Laboratory of Cancer Immunotherapy and Radiotherapy, Chinese Academy of Medical Sciences, Urumqi, 830000, Xinjiang, China. FAU - Kuerban, Gulina AU - Kuerban G AD - Department of Gynecology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, Xinjiang, China. FAU - Yao, Xuan AU - Yao X AD - MRC Human Immunology Unit, Weatherall Institute of MolecularMedicine, Oxford University, Oxford, OX3 9DS, UK. FAU - Peng, Yanchun AU - Peng Y AD - MRC Human Immunology Unit, Weatherall Institute of MolecularMedicine, Oxford University, Oxford, OX3 9DS, UK. FAU - Dong, Tao AU - Dong T AD - Nuffield Department of Medicine, CAMS Oxford Center for Translational Immunology, Chinese Academy of Medical Science Oxford Institute, Oxford University, Oxford, OX3 9DS, UK. tao.dong@imm.ox.ac.uk. AD - MRC Human Immunology Unit, Weatherall Institute of MolecularMedicine, Oxford University, Oxford, OX3 9DS, UK. tao.dong@imm.ox.ac.uk. FAU - Wang, Ruozheng AU - Wang R AUID- ORCID: 0000-0002-0524-1212 AD - Department of Radiation Oncology, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, 830000, Xinjiang, China. wrz8526@vip.163.com. AD - Key Laboratory of Cancer Immunotherapy and Radiotherapy, Chinese Academy of Medical Sciences, Urumqi, 830000, Xinjiang, China. wrz8526@vip.163.com. LA - eng GR - 2012DFA31560/International Science and Technology Cooperation Project of China/International GR - U1603282/Regional joint fund of the National Natural Science Foundation of China/International GR - MR/L018942/1/MRC_/Medical Research Council/United Kingdom GR - G0600520/MRC_/Medical Research Council/United Kingdom GR - G1001046/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180122 PL - Germany TA - Arch Gynecol Obstet JT - Archives of gynecology and obstetrics JID - 8710213 RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DRB1 Chains) SB - IM MH - Alleles MH - Asian People/*ethnology/*genetics MH - Carcinoma, Squamous Cell/*genetics MH - Epithelial Cells MH - Female MH - Gene Frequency MH - *Genetic Predisposition to Disease MH - Genotype MH - HLA-DQ beta-Chains/*genetics MH - HLA-DRB1 Chains/*genetics MH - Haplotypes/*genetics MH - Humans MH - Uterine Cervical Neoplasms/epidemiology/*genetics/prevention & control OTO - NOTNLM OT - Clinical outcome OT - Haplotype OT - Human leukocyte antigen (HLA) OT - Squamous cell cervical cancer (SCC) OT - Uyghur EDAT- 2018/01/23 06:00 MHDA- 2019/04/05 06:00 CRDT- 2018/01/23 06:00 PHST- 2017/10/24 00:00 [received] PHST- 2018/01/09 00:00 [accepted] PHST- 2018/01/23 06:00 [pubmed] PHST- 2019/04/05 06:00 [medline] PHST- 2018/01/23 06:00 [entrez] AID - 10.1007/s00404-018-4662-3 [pii] AID - 10.1007/s00404-018-4662-3 [doi] PST - ppublish SO - Arch Gynecol Obstet. 2018 Mar;297(3):757-766. doi: 10.1007/s00404-018-4662-3. Epub 2018 Jan 22.